ES2147841T3 - Derivados de piridazinona. - Google Patents
Derivados de piridazinona.Info
- Publication number
- ES2147841T3 ES2147841T3 ES95906505T ES95906505T ES2147841T3 ES 2147841 T3 ES2147841 T3 ES 2147841T3 ES 95906505 T ES95906505 T ES 95906505T ES 95906505 T ES95906505 T ES 95906505T ES 2147841 T3 ES2147841 T3 ES 2147841T3
- Authority
- ES
- Spain
- Prior art keywords
- hydrogen atom
- atom
- alkyl group
- group
- äwherein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/22—Nitrogen and oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
LOS DERIVADOS DE PIRIDAZINONA REPRESENTADOS POR LA FORMULA (I) Y AGENTES ANTIPLAQUETAS QUE LOS CONTIENEN: [EN DONDE R ES UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO C{SUB,1}C{SUB,4}, X ES UN ATOMO DE HIDROGENO, UN ATOMO DE CLORO O UN ATOMO DE BROMO, AR ES UN GRUPO PIRIDILO O UN GRUPO FENILO SUBSTITUIDO CON OR{SUP,1} (EN DONDE R{SUP,1} ES UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO C{SUB,1}-C{SUB,4}) Y A {EN DONDE A ES UN ATOMO DE HIDROGENO, UN ATOMO DE HALOGENO, UN GRUPO ALQUILO C{SUB,1}-C{SUB,4} U OR{SUP,2}(EN DONDE R{SUP,2} ES UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO C{SUB,1}-C{SUB,4})}, Y ES ALQUILENO C{SUB,1}-C{SUB,8} EN DONDE UN ATOMO DE CARBONO EN LA CADENA RECTA ES SUBSTITUIDO CON UN GRUPO OR{SUP,1} (EN DONDE R{SUP,1} ES EL MISMO DEFINIDO ANTERIORMENTE), Y Z{SUP,1} Y Z{SUP,2} SON INDEPENDIENTEMENTE UN ATOMO DE HIDROGENO, UN ATOMO DE HALOGENO, UN GRUPO ALQUILO C{SUB,1}-C{SUB,4} O UN GRUPO OR{SUP,1} (EN DONDE R{SUP,1} ES EL MISMO DEFINIDO ANTERIORMENTE)]. ESTOS COMPUESTOS TIENEN FUERTES EFECTOS ANTIPLAQUETA, SON EXCELENTEMENTE SEGUROS, Y PUEDEN SER USADOS COMO INGREDIENTES ACTIVOS DE PROFILACTICOS Y FARMACOS TERAPEUTICOS PARA VARIAS ENFERMEDADES TROMBOTICAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP654194 | 1994-01-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2147841T3 true ES2147841T3 (es) | 2000-10-01 |
Family
ID=11641211
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95906505T Expired - Lifetime ES2147841T3 (es) | 1994-01-25 | 1995-01-24 | Derivados de piridazinona. |
Country Status (16)
Country | Link |
---|---|
US (2) | US5750523A (es) |
EP (1) | EP0742211B1 (es) |
KR (1) | KR100318653B1 (es) |
CN (1) | CN1049892C (es) |
AT (1) | ATE192741T1 (es) |
AU (1) | AU1466395A (es) |
CA (1) | CA2181901C (es) |
DE (1) | DE69516849T2 (es) |
DK (1) | DK0742211T3 (es) |
ES (1) | ES2147841T3 (es) |
FI (1) | FI112214B (es) |
HU (1) | HU223963B1 (es) |
NO (1) | NO307965B1 (es) |
PT (1) | PT742211E (es) |
TW (1) | TW420665B (es) |
WO (1) | WO1995019969A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL110040A (en) * | 1993-06-29 | 2000-07-16 | Nissan Chemical Ind Ltd | Pyridazinone derivatives their preparation and pharmaceutical compositions comprising them |
TW482675B (en) * | 1997-01-31 | 2002-04-11 | Green Cross Corp | Compositions for oral administration containing pyridazinone compounds technical field of the invention |
DK1123704T3 (da) | 1998-09-01 | 2004-11-01 | Nissan Chemical Ind Ltd | Midler til spinalstenose |
IL143530A0 (en) * | 1998-12-07 | 2002-04-21 | Nissan Chemical Ind Ltd | Pyridazinone derivatives |
ES2195785B1 (es) * | 2002-05-16 | 2005-03-16 | Almirall Prodesfarma, S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
RU2339381C2 (ru) * | 2004-02-09 | 2008-11-27 | Ниссан Кемикал Индастриз, Лтд. | Ингибитор гиперплазии интимы сосудов |
KR100854584B1 (ko) | 2006-03-20 | 2008-08-27 | 주식회사 엘지생명과학 | 피리다지논, 피리미돈 또는 피리돈 구조를 포함하는선택적인 트롬빈 억제제 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0186817B1 (en) * | 1984-12-10 | 1989-08-02 | Nissan Chemical Industries Ltd. | 3(2h)pyridazinone, process for its preparation and anti-allergic agent containing it |
JPH0641454B2 (ja) * | 1985-02-27 | 1994-06-01 | 日産化学工業株式会社 | ピリダジノン誘導体 |
US4892947A (en) * | 1985-04-27 | 1990-01-09 | Nissan Chemical Industries Ltd. | 3(2H)Pyridazinone, process for its preparation and anti-allergic agent containing it |
US4978665A (en) * | 1987-01-20 | 1990-12-18 | Nissan Chemical Industries Ltd. | 3(2H)pyridazinone, and antagonistic agent against SRS-A containing it |
JPH02256668A (ja) * | 1988-12-20 | 1990-10-17 | Nissan Chem Ind Ltd | ピリダジノン誘導体 |
UA27031A1 (uk) * | 1990-04-25 | 2000-02-28 | Ніссан Кемікал Індастріз Лтд | Похідhі 3(2h)піридазиhоhу або їх фармацевтичhо прийhятhі солі, що мають протитромботичhу, позитивhу іhотропhу, судиhорозширювальhу дію й аhтиалергічhу активhість та фармацевтичhа композиція hа їх осhові |
JPH0517357A (ja) * | 1991-07-05 | 1993-01-26 | Nissan Chem Ind Ltd | 血小板減少療法剤 |
IL110040A (en) * | 1993-06-29 | 2000-07-16 | Nissan Chemical Ind Ltd | Pyridazinone derivatives their preparation and pharmaceutical compositions comprising them |
CN1056369C (zh) * | 1993-09-06 | 2000-09-13 | 石原产业株式会社 | 哒嗪酮衍生物或其盐和制备方法 |
-
1995
- 1995-01-24 WO PCT/JP1995/000069 patent/WO1995019969A1/ja active IP Right Grant
- 1995-01-24 ES ES95906505T patent/ES2147841T3/es not_active Expired - Lifetime
- 1995-01-24 KR KR1019960703941A patent/KR100318653B1/ko not_active IP Right Cessation
- 1995-01-24 US US08/676,227 patent/US5750523A/en not_active Expired - Lifetime
- 1995-01-24 CA CA002181901A patent/CA2181901C/en not_active Expired - Lifetime
- 1995-01-24 HU HU9602021A patent/HU223963B1/hu active IP Right Grant
- 1995-01-24 PT PT95906505T patent/PT742211E/pt unknown
- 1995-01-24 EP EP95906505A patent/EP0742211B1/en not_active Expired - Lifetime
- 1995-01-24 DK DK95906505T patent/DK0742211T3/da active
- 1995-01-24 AU AU14663/95A patent/AU1466395A/en not_active Abandoned
- 1995-01-24 CN CN95191304A patent/CN1049892C/zh not_active Expired - Lifetime
- 1995-01-24 DE DE69516849T patent/DE69516849T2/de not_active Expired - Lifetime
- 1995-01-24 AT AT95906505T patent/ATE192741T1/de active
- 1995-01-27 TW TW084100797A patent/TW420665B/zh not_active IP Right Cessation
-
1996
- 1996-07-24 FI FI962957A patent/FI112214B/fi not_active IP Right Cessation
- 1996-07-24 NO NO963095A patent/NO307965B1/no not_active IP Right Cessation
-
1997
- 1997-09-24 US US08/936,600 patent/US5856327A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2181901C (en) | 2005-09-13 |
FI112214B (fi) | 2003-11-14 |
NO963095L (no) | 1996-09-24 |
US5750523A (en) | 1998-05-12 |
DE69516849D1 (de) | 2000-06-15 |
WO1995019969A1 (fr) | 1995-07-27 |
CA2181901A1 (en) | 1995-07-27 |
CN1138852A (zh) | 1996-12-25 |
HU223963B1 (hu) | 2005-03-29 |
KR100318653B1 (ko) | 2002-04-22 |
NO307965B1 (no) | 2000-06-26 |
EP0742211B1 (en) | 2000-05-10 |
NO963095D0 (no) | 1996-07-24 |
HUT74742A (en) | 1997-02-28 |
TW420665B (en) | 2001-02-01 |
ATE192741T1 (de) | 2000-05-15 |
FI962957A0 (fi) | 1996-07-24 |
US5856327A (en) | 1999-01-05 |
EP0742211A4 (en) | 1997-03-26 |
DK0742211T3 (da) | 2000-08-14 |
DE69516849T2 (de) | 2000-10-12 |
PT742211E (pt) | 2000-10-31 |
AU1466395A (en) | 1995-08-08 |
FI962957A (fi) | 1996-07-24 |
HU9602021D0 (en) | 1996-09-30 |
EP0742211A1 (en) | 1996-11-13 |
CN1049892C (zh) | 2000-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE225770T1 (de) | Difluoroprostaglandin-derivate und ihre anwendung | |
AU591640B2 (en) | Quinolonecarboxylic acid derivatives | |
ATE143014T1 (de) | Benzimidazol-derivate und therapeutische, diese enthaltende mittel gegen ulcer | |
DE69505470T2 (de) | Pyrrolocarbazol | |
DE3767778D1 (de) | Entzuendung verhindernde und allergie heilende mittel. | |
EP0259835A3 (en) | Pyridazinone derivatives | |
ES2147841T3 (es) | Derivados de piridazinona. | |
MX9701949A (es) | Derivados de distamicina substituidos con bis-(2-haloetil) aminofenilo como agentes antitumorales y antivirales. | |
ATE9892T1 (de) | Dibenzocycloheptenylidene und ihre verwendung in pharmazeutischen zusammensetzungen. | |
DE69112095D1 (de) | 1-Phenoxycarbonyl-2-Pyrrolidon-Derivate und nootrope Wirkstoffe. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 742211 Country of ref document: ES |